alt

Michael A. Nauck

Michael A. Nauck

Michael Nauck is Head of Clinical Research at the Diabetes Division of St. JosefHospital (Ruhr-University Bochum) in Bochum, Germany. Professor Nauck has a particular research interest in the role of gastrointestinal peptide hormones (incretins: glucose-dependent insulinotropic polypeptide, GIP, and glucagon-like peptide-1, GLP-1) in the physiological regulation of metabolism and in the pathophysiology of type 2 diabetes. He has contributed pivotal studies proving a therapeutic potential of GLP-1 in type 2 diabetes. He has contributed to the development of incretin-based glucose-lowering medications such as GLP-1 receptor agonists and inhibitors of dipeptidyl peptidase-4. Additional areas of interest include spontaneous hypoglycaemia (insulinomas), pancreas transplantation, cardiovascular complications of type 2 diabetes, and the modification of cardiovascular risk in type 2-diabetic patients with glucose-lowering pharmacotherapy. His scientific contributions have been honoured with several awards, including the FerdinandBertram Award (1993), the Werner-Creutzfeldt Award (2007) and the Paul Langerhans Medal (2012) from the German Diabetes Association, and the Claude Bernard Medal from the European Association for the Study of Diabetes (2022). He has served as reviewer for all major diabetes journals and has published more than 250 original articles and 140 reviews and book chapters. His publications have been quoted > 70000 times, his “H-index” is 109, and he has been a “highly-cited researcher” (among the top 1 %) in 2019, 2021, and 2022 (Web of Knowledge). Professor Nauck is member of a number of professional societies, including the German, European, American Diabetes Associations, and the International Diabetes Federation.

Curriculum Vitae

Michael A. Nauck, MD, Dr h.c., is Head of Clinical Research in the Diabetes Division of the Katholisches Klinikum Bochum, St. Josef-Hospital (Ruhr-University Bochum), Germany. From 2000 to 2014 he was Head Physician of the Diabetes Center Bad Lauterberg, a specialised hospital for patients with diabetes and other metabolic diseases.

His academic and research contributions are extensive, including:

  • Incretin research: His work has focused on the role of gastrointestinal peptide hormones such as GIP and GLP-1 in the stimulation of insulin secretion and on incretin-based medications, including GLP-1 receptor agonists.
  • Academic career: He trained in internal medicine, gastroenterology and endocrinology at the Georg-August University of Göttingen and holds the title of Extraordinary Professor at Ruhr-University Bochum.
  • Recognition: He received an honorary doctorate from the University of Copenhagen in 2016.

Professor Nauck is a specialist in internal medicine, gastroenterology, endocrinology and diabetology.